The study drug is a potential new treatment for moderate to severe uncontrolled asthma.
The purpose of this study is to investigate a potential new treatment for moderate to severe uncontrolled asthma.
Asthma is a common, long-term respiratory condition that affects people all over the world. It causes problems with breathing due to narrowed airways, excessive mucus, and inflammation.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!